Client Testimonials

At Singulex, achieving total customer satisfaction is our ultimate goal, and we are proud of the feedback we receive. We invite you to read the testimonials below to learn how Singulex technology and services have helped our clients successfully reach their research goals.


"The Erenna system has become a very important technology for our central lab when pharmaceutical companies come to us requiring high sensitivity measurements."
Ole Vesterqvist, Senior Director of Clinical Laboratory Science at Covance, Inc. Dr. Vesterqvist shares his thoughts on the benefits of bringing high-sensitivity immunoassay technologies into pharma/CRO settings. Download the full article here.
"In summary, the advantages for this assay are its sensitivity, low sample volume requirement, broad standard curve range, and 1-step capture and detection step."
Elizabeth Macy, Senior Research Technician at Washington University Diabetes Research and Training Center, Proteomics Core. Ms. Macy provides an expert review of the Erenna Mouse (Plate-based) Insulin Immunoassay Kit. Read the product review on Biocompare.
"Using the Singulex immunoassay-based method, called Single Molecule Detection, we can pick up troponin at the lowest picogram [per mL] levels, which is a whole order of magnitude more sensitive. We know it measures below the present 99^th percentile of currently available troponin assays, and that alone is highly valuable."
Nate Lebowitz, M.D., F.A.C.C. Advanced Cardiology Institute. Dr. Lebowitz explains the utility of the CVMedHome Cardiovascular Advanced Testing and Wellness Program, and presents several successful patient studies from his cardiology practice. Watch the 4-part video series on YouTube: Part 1: Benefits and Opportunity Part 2: Sgx HD cTnI test Part 3: Advanced Lipid Panel Part 4: CVMedHome Wellness Program

Want to be our technology advocate, or have comments about how we can improve our products or services? Contact us at customer.relations@singulex.com and we will get in touch with you shortly.